These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 11354321

  • 1. The association between preoperative concentration of soluble vascular endothelial growth factor, perioperative blood transfusion, and survival in patients with primary colorectal cancer.
    Werther K, Christensen IJ, Nielsen HJ, Danish RANX05 Colorectal Cancer Study Group.
    Eur J Surg; 2001 Apr; 167(4):287-92. PubMed ID: 11354321
    [Abstract] [Full Text] [Related]

  • 2. Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group.
    Werther K, Christensen IJ, Brünner N, Nielsen HJ.
    Eur J Surg Oncol; 2000 Nov; 26(7):657-62. PubMed ID: 11078612
    [Abstract] [Full Text] [Related]

  • 3. Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer.
    Kumar H, Heer K, Lee PW, Duthie GS, MacDonald AW, Greenman J, Kerin MJ, Monson JR.
    Clin Cancer Res; 1998 May; 4(5):1279-85. PubMed ID: 9607588
    [Abstract] [Full Text] [Related]

  • 4. Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Danish RANX05 Colorectal Cancer Study Group.
    Mynster T, Christensen IJ, Moesgaard F, Nielsen HJ.
    Br J Surg; 2000 Nov; 87(11):1553-62. PubMed ID: 11091245
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Adverse effects of perioperative blood transfusion in patients with colorectal cancer.
    Jahnson S, Andersson M.
    Eur J Surg; 1992 Aug; 158(8):419-25. PubMed ID: 1356481
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer.
    Chin KF, Greenman J, Gardiner E, Kumar H, Topping K, Monson J.
    Br J Cancer; 2000 Dec; 83(11):1425-31. PubMed ID: 11076648
    [Abstract] [Full Text] [Related]

  • 9. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.
    Tsai WS, Changchien CR, Yeh CY, Chen JS, Tang R, Chiang JM, Hsieh PS, Fan CW, Wang JY.
    Dis Colon Rectum; 2006 Jun; 49(6):883-94. PubMed ID: 16741643
    [Abstract] [Full Text] [Related]

  • 10. Clinical significance of serum vascular endothelial growth factor in colorectal cancer patients: correlation with clinicopathological factors and tumor markers.
    Takeda A, Shimada H, Imaseki H, Okazumi S, Natsume T, Suzuki T, Ochiai T.
    Oncol Rep; 2000 Jun; 7(2):333-8. PubMed ID: 10671682
    [Abstract] [Full Text] [Related]

  • 11. Preoperative serum vascular endothelial growth factor-a is a marker for subsequent recurrence in colorectal cancer patients.
    Alabi AA, Suppiah A, Madden LA, Monson JR, Greenman J.
    Dis Colon Rectum; 2009 May; 52(5):993-9. PubMed ID: 19502868
    [Abstract] [Full Text] [Related]

  • 12. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.
    Miyazaki T, Okada N, Ishibashi K, Ogata K, Ohsawa T, Ishiguro T, Nakada H, Yokoyama M, Matsuki M, Kato H, Kuwano H, Ishida H.
    Jpn J Clin Oncol; 2008 Dec; 38(12):839-43. PubMed ID: 18923001
    [Abstract] [Full Text] [Related]

  • 13. Association between transfusion of stored blood and infective bacterial complications after resection for colorectal cancer.
    Edna TH, Bjerkeset T.
    Eur J Surg; 1998 Jun; 164(6):449-56. PubMed ID: 9696446
    [Abstract] [Full Text] [Related]

  • 14. Vascular endothelial growth factor and psychosocial factors in colorectal cancer.
    Sharma A, Greenman J, Sharp DM, Walker LG, Monson JR.
    Psychooncology; 2008 Jan; 17(1):66-73. PubMed ID: 17410522
    [Abstract] [Full Text] [Related]

  • 15. Preoperative serum vascular endothelial growth factor is not a marker for subsequent recurrence during long-term follow-up of colorectal cancer patients.
    Roumen RM, Slooter GD, Croiset van Uchelen FA, Huib LV.
    Dis Colon Rectum; 2005 May; 48(5):1070-5. PubMed ID: 15785896
    [Abstract] [Full Text] [Related]

  • 16. Kinetics of postoperative serum vascular endothelial growth factor (VEGF)--can it be used to predict curative resections in colorectal cancer?
    Kumar H, Heer K, Duthie GS, Monson JR.
    Anticancer Res; 2002 May; 22(6B):3717-22. PubMed ID: 12552982
    [Abstract] [Full Text] [Related]

  • 17. Ranitidine as adjuvant treatment in colorectal cancer.
    Nielsen HJ, Christensen IJ, Moesgaard F, Kehlet H, Danish RANX05 Colorectal Cancer Study Group.
    Br J Surg; 2002 Nov; 89(11):1416-22. PubMed ID: 12390384
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of plasma vascular endothelial growth factor in patients with colorectal cancer.
    Nakayama Y, Sako T, Shibao K, Okazaki K, Rempo N, Onitsuka K, Minagawa N, Akahane K, Nagashima N, Nagata N, Itoh H.
    Anticancer Res; 2002 Nov; 22(4):2437-42. PubMed ID: 12174940
    [Abstract] [Full Text] [Related]

  • 19. Association between blood transfusion and survival in a randomised multicentre trial of perioperative adjuvant portal chemotherapy in patients with colorectal cancer. The Swiss Group for Clinical Cancer Research (SAKK).
    Eur J Surg; 1997 Sep; 163(9):693-701. PubMed ID: 9311477
    [Abstract] [Full Text] [Related]

  • 20. Vascular endothelial growth factor expression in metastatic pulmonary tumor from colorectal carcinoma: utility as a prognostic factor.
    Tamura M, Oda M, Tsunezuka Y, Matsumoto I, Kawakami K, Watanabe G.
    J Thorac Cardiovasc Surg; 2004 Oct; 128(4):517-22. PubMed ID: 15457151
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.